| Mr Julius Brandon Elmore, MD | |
|
1062 Forsyth St Ste 1b, Macon, GA 31201-8638 | |
| (478) 741-1208 | |
| Not Available |
| Full Name | Mr Julius Brandon Elmore |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 16 Years |
| Location | 1062 Forsyth St Ste 1b, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457523367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 078025 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center, Navicent Health (the) | Macon, GA | Hospital |
| Houston Medical Center | Warner robins, GA | Hospital |
| Navicent Health Baldwin | Milledgeville, GA | Hospital |
| Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Georgia Heart Center, Pc | 0446248736 | 25 |
| Health Services Of Central Georgia | 9638076730 | 205 |
News Archive
A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.
An alarming trend shows that girls as young as primary-school age are increasingly troubled by their self-image, with more than a third of those aged between 10 and 11 eager to lose weight and adopting drastic methods to pursue their ideal body shape.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
The human genome project captured the public imagination when its first draft was published 14 years ago this week in the international science journal Nature, but the epigenome may hold the real promise for conquering disease.
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
› Verified 2 days ago
| Entity Name | Health Services Of Central Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184679482 PECOS PAC ID: 9638076730 Enrollment ID: O20031217000270 |
News Archive
A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.
An alarming trend shows that girls as young as primary-school age are increasingly troubled by their self-image, with more than a third of those aged between 10 and 11 eager to lose weight and adopting drastic methods to pursue their ideal body shape.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
The human genome project captured the public imagination when its first draft was published 14 years ago this week in the international science journal Nature, but the epigenome may hold the real promise for conquering disease.
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
› Verified 2 days ago
| Entity Name | Central Georgia Heart Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780779363 PECOS PAC ID: 0446248736 Enrollment ID: O20040505000220 |
News Archive
A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.
An alarming trend shows that girls as young as primary-school age are increasingly troubled by their self-image, with more than a third of those aged between 10 and 11 eager to lose weight and adopting drastic methods to pursue their ideal body shape.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
The human genome project captured the public imagination when its first draft was published 14 years ago this week in the international science journal Nature, but the epigenome may hold the real promise for conquering disease.
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Julius Brandon Elmore, MD 1062 Forsyth St, Ste 1b, Macon, GA 31201-8638 Ph: (478) 741-1208 | Mr Julius Brandon Elmore, MD 1062 Forsyth St Ste 1b, Macon, GA 31201-8638 Ph: (478) 741-1208 |
News Archive
A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson's disease.
An alarming trend shows that girls as young as primary-school age are increasingly troubled by their self-image, with more than a third of those aged between 10 and 11 eager to lose weight and adopting drastic methods to pursue their ideal body shape.
Researchers from the Universitat Politècnica de Catalunya · BarcelonaTech (UPC), the Instituto de Química Mèdica (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria.
The human genome project captured the public imagination when its first draft was published 14 years ago this week in the international science journal Nature, but the epigenome may hold the real promise for conquering disease.
GE Healthcare, a unit of the General Electric Company, today will present results of a phase 1 study of anti-[18F]FACBC at the 57th annual meeting of the Society of Nuclear Medicine in Salt Lake City, Utah. The presentation closely follows the launch of the phase 2 clinical development program for anti-[18F]FACBC, which was initially discovered and developed by Emory University, Atlanta, Georgia, and was licensed to Nihon Medi-Physics Co., Ltd. (NMP) of Japan.
› Verified 2 days ago
Mrs. Mary E Mckinley, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 360 Hospital Dr, Suite 110, Macon, GA 31217 Phone: 478-841-2707 Fax: 478-841-2708 | |
Dr. Swathi Singanamala, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 640 Martin Luther King Jr Blvd, Suite 200, Macon, GA 31201 Phone: 478-745-5455 Fax: 478-803-5232 | |
Dr. Sebastian Alan Montgomery, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 380 Hospital Dr Ste 430, Macon, GA 31217 Phone: 478-751-0480 | |
Sagar Jayant Panse, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 890 2nd St, Suite 201, Macon, GA 31201 Phone: 478-745-4322 Fax: 478-750-8789 | |
Dr. Rana K Munna, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 107 Preston Ct, Macon, GA 31210 Phone: 478-238-0771 Fax: 478-238-6688 | |
Oliver Wendell Horne Iv, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1062 Forsyth St Ste 1b, Macon, GA 31201 Phone: 478-741-1208 | |
Thomas P Meyer, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 360 Hospital Dr Bldg D, Suite 200, Macon, GA 31217 Phone: 478-745-5476 Fax: 478-745-3768 |